Klin Farmakol Farm. 2014;28(1):26-30

Effect of the infusion system on the quality of parenteral treatment

Karel Urbánek, Martin Poruba, Pavlína Štrbová
Ústav farmakologie Lékařské fakulty Univerzity Palackého a Fakultní nemocnice Olomouc

Currently used containers for intravenous infusion solutions are primarily PVC or non-PVC collapsible and semi-rigid plastic containers. Main

advantage of flexible containers is the fact that they do not need venting for optimal emptying, thus can be used in closed infusion systems. This

minimizes the risk of contamination by the pathogens from the environment, reducing the risk of serious nosocomial infections. Furthermore,

after the use only a small residual volume remains in the container, which means that the dosage of the dissolved medicaments is very accurate.

Keywords: parenteral treatment, infusion containers, closed system, blood stream infection

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Urbánek K, Poruba M, Štrbová P. Effect of the infusion system on the quality of parenteral treatment. Klin Farmakol Farm. 2014;28(1):26-30.
Download citation

References

  1. Český lékopis 2009. Praha, Grada, 2009.
  2. Maki DG, Rosenthal VD, Salomao R, Franzetti F, Rangel-Frausto MS. Impact of Switching from an Open to a Closed Infusion System on Rates of Central Line-Associated Bloodstream Infection: A Meta-analysis of Time-Sequence Cohort Studies in 4 Countries. Infection Control and Hospital Epidemiology 2011; 32: 50-58. Go to original source... Go to PubMed...
  3. Gabay M, von Martius K. Comparative evaluation of collapsible versus semirigid intravenous containers. Technology and Health Care 2008; 16: 429-435. Go to original source...
  4. The Joint Commission. Preventing Central Line-Associated Bloodstream Infections: A Global Challenge, a Global Perspective. Oak Brook, IL: Joint Commission Resources, May 2012.
  5. Prokešová V. K prevenci vzniku nozokomiálních nákaz z pohledu klinického farmaceuta. Florence 2013; 13: 31-32. Dostupné na www.florence.cz.
  6. Graves N, Barnett AG, Rosenthal VD. Open versus closed IV infusion systems: a state based model to predict risk of catheter associated blood stream infections. BMJ Open 2011; 1: e000188. Go to original source... Go to PubMed...
  7. Kapounová G. Ošetřovatelství v intenzivní péči. Praha: Grada, 2007.
  8. Lannoy D, Décaudin B, von Martius K, Odou P. Comparison of container system residual volumes and the implications for medication error. European Journal of Hospital Pharmacy (2012), e-pub: doi: 10.1136/ejhpharm-2011-000048. Go to original source...
  9. Rosenthal VD, Maki DG. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia. Am J Infect Control 2004; 32: 135-141. Go to original source... Go to PubMed...
  10. Hoefel HH, Lautert L. Errors committed by nursing technicians and assistants in administering antibiotics. American Journal of Infection Control 2006; 34: 437-442. Go to original source... Go to PubMed...
  11. Rangel-Frausto MS, Higuera-Ramirez F, Martinez-Soto J, Rosenthal VD. Should we use close or open infusion containers for prevention of bloodstream infections? Annals of Clinical Microbiology and Antimicrobials 2010; 38: 217-221. Go to original source... Go to PubMed...
  12. Martin JH, Norris R, Barras M, Roberts J, Morris R, Doogue M, Jones GR. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists. Clin Biochem Rev. 2010; 31(1): 21-24. Go to PubMed...
  13. Claus BO, Hoste EA, Colpaert K, Robays H, Decruyenaere J, De Waele JJ. Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care. 2013; 28(5): 695-700. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.